Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TechnologyAdvice

- PMLiVE

FDA knocks back J&J and Bayer’s Xarelto in ACS

Follows unanimous negative committee vote

- PMLiVE

EFPIA looks to Lilly for head of comms

Pharma trade body hires Liam English

- PMLiVE

What’s holding you back in creating a successful business model?

Don’t get left behind in the race to find a successful new business model in the pharma industry

- PMLiVE

EMA to expand orphan drug HTA collaboration

Will further develop the concept of parallel scientific advice in 2014

Mallinckrodt offers $1.3bn for Cadence Pharma

Deal would include injectable painkiller Ofirmev

- PMLiVE

FDA knocks back Durect’s painkiller

Regulator wants more safety information for Posidur

- PMLiVE

Shire to file Vyvanse for binge-eating in Q3

Wants to mirror drug’s success as ADHD treatment

- PMLiVE

Pharma’s reputation stays low in 2013

Patient group survey ranks pharma second bottom among healthcare industries

- PMLiVE

Merck appoints new legal and auditing heads

Friederike Rotsch and Barbara Weiland take on senior roles

- PMLiVE

Blue Rubicon buys Open Road

Acquisition creates an ‘independent powerhouse’, say the agencies.

- PMLiVE

FDA approves clinical trial wearables

Greenlights Camntech's MotionWatch and Pro-Diary medical devices

Deal Watch table for January 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links